Provides working party recommendations for the screening and management of chronic kidney disease to prevent progression and reduce cardiovascular mortality.
Standardizes CKD screening and management to curb progression and CV mortality; extends evidence synthesis into updated clinical recommendations.
End-stage renal disease (ESRD) is a major health problem associated with considerable increase in morbidity and mortality and with decreased quality of life. To slow the progression of kidney failure, to prevent the consequences of chronic kidney disease (CKD) and to decrease cardiovascular mortality associated with CKD, it is crucial to detect patients with CKD early and to optimize their care. To assist physicians in patient management, members of a working party for the management of CKD have identified several recommendations for the screening of patients at risk of CKD and for the management of patients with established CKD.
No takes yet. Share an insight, caveat, or question.
Rossert et al. (2002) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: